行情

PAHC

PAHC

Phibro Animl
NASDAQ

实时行情|Nasdaq Last Sale

23.27
-0.29
-1.23%
盘后: 23.27 0 0.00% 16:00 04/08 EDT
开盘
23.82
昨收
23.56
最高
23.82
最低
22.97
成交量
11.39万
成交额
--
52周最高
36.98
52周最低
16.87
市值
9.41亿
市盈率(TTM)
24.92
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测PAHC价格均价为22.75,最高价位25.00,最低价为18.00。

EPS

PAHC 新闻

更多
  • 沪指横盘震荡 标普500暂时脱离“技术性熊市”
  • 新浪财经 · 10分钟前
  • 趣店跨界做奢侈品电商 百亿补贴引流背后前景难料
  • 投中网 · 1小时前
  • 新冠肺炎疫情蔓延 墨西哥已削减近35万个工作岗位
  • 中国新闻网 · 1小时前
  • 美媒:最新研究显示纽约的疫情主要是欧洲输入
  • 央视 · 1小时前

所属板块

制药
+2.77%
制药与医学研究
+2.82%

热门股票

代码
价格
涨跌幅

PAHC 简况

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
展开

微牛提供Phibro Animal Health Corp(NASDAQ-PAHC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的PAHC股票新闻,以帮助您做出投资决策。